r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

BB

Bruce Booth

Insider · Director · KYMR

Bruce Booth files insider transactions with the SEC as a director of Kymera Therapeutics (KYMR). We hold 16 disclosed purchases and sales filed since 26 June 2014, 12 of them in the last 90 days.

  • Files forKYMR
  • Disclosed buys and sells16 in all, 12 in the last 90 days
  • Last disclosure2 July 2026

Positions held

8 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 August 2020 — 29 June 2026Director · Kymera Therapeutics (KYMR)255 Form 4 lines · source: SEC Form 4
  • Filed 10 February 2025 — 17 June 2026Director · Sionna Therapeutics (SION)60 Form 4 lines · source: SEC Form 4
  • Filed 11 January 2022 — 5 August 2025Director · Vigil Neuroscience (VIGL)31 Form 4 lines · source: SEC Form 4
  • Filed 25 June 2018 — 6 June 2023Director · Avrobio (AVRO)13 Form 4 lines · source: SEC Form 4
  • Filed 25 June 2018 — 28 June 2022Director · Magenta Therapeutics (MGTA)11 Form 4 lines · source: SEC Form 4
  • Filed 3 April 2018 — 1 July 2020Director · Unum Therapeutics (UMRX)16 Form 4 lines · source: SEC Form 4
  • Filed 24 March 2017 — 27 June 2018Director · Miragen Therapeutics (MGEN)5 Form 4 lines · source: SEC Form 4
  • Filed 24 June 2014 — 3 January 2018Director and 10% owner · Zafgen (ZFGN)15 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.